Ballester, M. P., Carbonell-Asins, J., Elshabrawi, A., Rubin, D., Winkle, P., Lawitz, E., . . . Jalan, R. (2026). A Randomized, Open-Label, Phase 2a Study to Assess the Safety, Pharmacodynamics, and Pharmacokinetics of YAQ007 Versus Rifaximin in Cirrhosis. Zenodo.
Style de citation Chicago (17e éd.)Ballester, Maria Pilar, et al. A Randomized, Open-Label, Phase 2a Study to Assess the Safety, Pharmacodynamics, and Pharmacokinetics of YAQ007 Versus Rifaximin in Cirrhosis. Zenodo, 2026.
Style de citation MLA (9e éd.)Ballester, Maria Pilar, et al. A Randomized, Open-Label, Phase 2a Study to Assess the Safety, Pharmacodynamics, and Pharmacokinetics of YAQ007 Versus Rifaximin in Cirrhosis. Zenodo, 2026.
Attention : ces citations peuvent ne pas être correctes à 100%.